欢迎来到《四川大学学报(医学版)》
张斌, 马倩, 马富珍, 等. 黄芪甲苷对心肌细胞缺氧/复氧损伤的保护作用及其自噬机制研究[J]. 四川大学学报(医学版), 2021, 52(2): 222-228. DOI: 10.12182/20201260601
引用本文: 张斌, 马倩, 马富珍, 等. 黄芪甲苷对心肌细胞缺氧/复氧损伤的保护作用及其自噬机制研究[J]. 四川大学学报(医学版), 2021, 52(2): 222-228. DOI: 10.12182/20201260601
ZHANG Bin, MA Qian, MA Fu-zhen, et al. Astragaloside Ⅳ’s Therapeutic Effect on Myocardial Infarction via Affecting Autophagy and the Mechanism Study[J]. Journal of Sichuan University (Medical Sciences), 2021, 52(2): 222-228. DOI: 10.12182/20201260601
Citation: ZHANG Bin, MA Qian, MA Fu-zhen, et al. Astragaloside Ⅳ’s Therapeutic Effect on Myocardial Infarction via Affecting Autophagy and the Mechanism Study[J]. Journal of Sichuan University (Medical Sciences), 2021, 52(2): 222-228. DOI: 10.12182/20201260601

黄芪甲苷对心肌细胞缺氧/复氧损伤的保护作用及其自噬机制研究

Astragaloside Ⅳ’s Therapeutic Effect on Myocardial Infarction via Affecting Autophagy and the Mechanism Study

  • 摘要:
      目的  研究黄芪甲苷(AS-Ⅳ)对新生大鼠心肌细胞缺氧/复氧(H/R)损伤的保护作用,并探讨其潜在的作用机制。
      方法  提取并培养新生大鼠心肌细胞,随机分为6组:对照组,H/R组,H/R+低、中、高浓度AS-Ⅳ(AS-Ⅳ终浓度0.1 μmol/L、1 μmol/L、10 μmol/L)组,和H/R+高浓度AS-Ⅳ(10 μmol/L)+AKT抑制剂(5 μmol/L)组。H/R前分组预处理心肌细胞(对照组和H/R组不进行预处理)48 h后,除对照组外,其余各组心肌细胞建立细胞H/R损伤模型。MTT法检测各组心肌细胞活力,实时荧光定量PCR(RT-qPCR)检测自噬基因LC3-Ⅱ、p62的表达,Western blot 检测LC3-Ⅱ、P62蛋白和磷脂酰肌醇3激酶/丝氨酸苏氨酸蛋白激酶(PI3K/AKT)通路蛋白〔包括AKT、磷酸化(p-)AKT(p-AKT)、p-雷帕霉素(p-mTOR)〕和自噬启动因子未配位的51样激酶1(ULK1)的表达,免疫荧光染色检测心肌细胞自噬体P62的表达。
      结果  AS-Ⅳ在本研究低、中、高浓度范围内以浓度依赖的方式改善H/R损伤下心肌细胞活力,并抑制H/R损伤后的心肌细胞自噬基因LC3-Ⅱ和p62 mRNA和蛋白的表达,抑制ULK1蛋白的表达(P<0.05),添加AKT抑制剂后,AS-Ⅳ的以上作用被部分抑制(P<0.05)。AS-Ⅳ对AKT和mTOR蛋白的表达没有影响(P>0.05),但可以促进AKT和mTOR的磷酸化(P<0.05)。免疫荧光染色检测结果显示,高浓度AS-Ⅳ可以逆转H/R损伤诱导的自噬体P62的表达。
      结论  AS-Ⅳ对H/R损伤心肌细胞具有保护作用,其作用机制可能是通过激活PI3K/AKT途径中的mTOR信号降低自噬水平,从而预防H/R损伤。

     

    Abstract:
      Objective  The purpose of this study was to investigate the protective effect of astragaloside Ⅳ (AS-Ⅳ) on neonatal rats’ hypoxic/reoxygenated (H/R) injured myocardial cells and to explore its underlying mechanism.
      Methods  Cardiac cells were extracted from newborn rats and divided into control, H/R, H/R-low AS-Ⅳ (0.1 μmol/L AS-Ⅳ), H/R-medium AS-Ⅳ (1 μmol/L AS-Ⅳ), H/R-high AS-Ⅳ (10 μmol/L AS-Ⅳ) and H/R-high AS-Ⅳ-AKT (10 μmol/L AS-Ⅳ+5 μmol/L AKT) groups. After 48 h of treatment, the contents of LC3-Ⅱ, p62, AKT, pAKT, rapamycin (mTOR) mammalian targets and uncoordinated 51-like kinase 1 (ULK1) in cardiac myocytes were compared. Immunofluorescence staining was used to detect the expression of P62 in myocardium autophagosome.
      Restults  AS-Ⅳ improved the proliferative activity of cardio AS-Ⅳ improved the proliferative activity of cardiomyocytes in H/R injury in a dose-dependent manner and inhibited the level of cell autophagy. However, when AKT inhibitors were added, the effect of AS-Ⅳ was partially inhibited (P<0.05). Gene and protein expression showed that AS-Ⅳ had no significant effect on the expression of AKT and mTOR genes (P>0.05), but could significantly promote the phosphorylation of AKT and mTOR (P<0.05). Immunofluorescence staining results showed that high concentrations of the AS - Ⅳ can reverse H/R injury induced the expression of autophagy body P62.
      Conclusion  AS-Ⅳ showed protection effect on H/R injured myocardial cells. The possible mechanism is by reducing the autophagy level via activating the mTOR signal in the PI3K/AKT pathway, thereby preventing H/R damage in neonatal rat cardiomyocytes.

     

/

返回文章
返回